DE602007010041D1 - Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs - Google Patents
Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebsInfo
- Publication number
- DE602007010041D1 DE602007010041D1 DE602007010041T DE602007010041T DE602007010041D1 DE 602007010041 D1 DE602007010041 D1 DE 602007010041D1 DE 602007010041 T DE602007010041 T DE 602007010041T DE 602007010041 T DE602007010041 T DE 602007010041T DE 602007010041 D1 DE602007010041 D1 DE 602007010041D1
- Authority
- DE
- Germany
- Prior art keywords
- aminomethyl
- hydrogen
- halo
- alkyl
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- IDNYTLARUCTDGK-UHFFFAOYSA-N 1-(pyrimidin-2-ylamino)imidazolidin-2-one Chemical class N1(C(NCC1)=O)NC1=NC=CC=N1 IDNYTLARUCTDGK-UHFFFAOYSA-N 0.000 title 1
- -1 N-ethyl-N-methyl-aminomethyl Chemical group 0.000 abstract 9
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 abstract 3
- 125000001475 halogen functional group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- VLUNZXPZDFIDHY-UHFFFAOYSA-N 1-(2-aminopyrimidin-4-yl)imidazolidin-2-one Chemical class NC1=NC=CC(N2C(NCC2)=O)=N1 VLUNZXPZDFIDHY-UHFFFAOYSA-N 0.000 abstract 1
- LLAPDLPYIYKTGQ-UHFFFAOYSA-N 1-aminoethyl Chemical group C[CH]N LLAPDLPYIYKTGQ-UHFFFAOYSA-N 0.000 abstract 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 abstract 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 abstract 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 108010056274 polo-like kinase 1 Proteins 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87132206P | 2006-12-21 | 2006-12-21 | |
| PCT/US2007/087046 WO2008076705A1 (en) | 2006-12-21 | 2007-12-11 | Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602007010041D1 true DE602007010041D1 (de) | 2010-12-02 |
Family
ID=39185681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602007010041T Active DE602007010041D1 (de) | 2006-12-21 | 2007-12-11 | Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8063212B2 (enExample) |
| EP (1) | EP2125794B1 (enExample) |
| JP (1) | JP2010513553A (enExample) |
| KR (1) | KR101080594B1 (enExample) |
| CN (1) | CN101568539B (enExample) |
| AT (1) | ATE485291T1 (enExample) |
| AU (1) | AU2007334040B2 (enExample) |
| BR (1) | BRPI0720607A2 (enExample) |
| CA (1) | CA2673564A1 (enExample) |
| CY (1) | CY1110950T1 (enExample) |
| DE (1) | DE602007010041D1 (enExample) |
| DK (1) | DK2125794T3 (enExample) |
| EA (1) | EA016178B1 (enExample) |
| ES (1) | ES2351371T3 (enExample) |
| HR (1) | HRP20100641T1 (enExample) |
| MX (1) | MX2009006635A (enExample) |
| PL (1) | PL2125794T3 (enExample) |
| PT (1) | PT2125794E (enExample) |
| RS (1) | RS51526B (enExample) |
| SI (1) | SI2125794T1 (enExample) |
| WO (1) | WO2008076705A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE479680T1 (de) | 2006-12-21 | 2010-09-15 | Lilly Co Eli | Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs |
| TW200908981A (en) * | 2007-05-16 | 2009-03-01 | Lilly Co Eli | Triazolyl aminopyrimidine compounds |
| CN104781257A (zh) | 2012-06-14 | 2015-07-15 | 第一三共株式会社 | 哌啶基吡唑并吡啶衍生物 |
| EP2929883A1 (en) | 2014-04-08 | 2015-10-14 | Institut Pasteur | Pyrazole derivatives as dihydroorotate dehydrogenase (DHODH) inhibitors |
| KR102693614B1 (ko) | 2022-04-04 | 2024-08-08 | 경희대학교 산학협력단 | 나프탈렌-2-일알킬기가 치환된 이미다졸리움 유도체 및 이를 유효성분으로 포함하는 암 치료용 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4929726A (en) | 1988-02-09 | 1990-05-29 | Georgia State University Foundation, Inc. | Novel diazines and their method of preparation |
| WO2004063192A1 (en) | 2003-01-10 | 2004-07-29 | Pharmacopeia Drug Discovery, Inc. | Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators |
| GB0308466D0 (en) | 2003-04-11 | 2003-05-21 | Novartis Ag | Organic compounds |
| CN101115749B (zh) * | 2004-12-17 | 2011-06-22 | 安姆根有限公司 | 氨基嘧啶化合物和使用方法 |
| TW200800201A (en) * | 2005-11-18 | 2008-01-01 | Lilly Co Eli | Pyrimidinyl benzothiophene compounds |
| EP2001480A4 (en) * | 2006-03-31 | 2011-06-15 | Abbott Lab | Indazole CONNECTIONS |
| ATE479680T1 (de) | 2006-12-21 | 2010-09-15 | Lilly Co Eli | Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs |
| EP2155735A2 (en) | 2007-05-16 | 2010-02-24 | Eli Lilly And Company | Triazolyl aminopyrimidine compounds |
| TW200908981A (en) | 2007-05-16 | 2009-03-01 | Lilly Co Eli | Triazolyl aminopyrimidine compounds |
-
2007
- 2007-12-11 EA EA200970616A patent/EA016178B1/ru not_active IP Right Cessation
- 2007-12-11 DK DK07855060.5T patent/DK2125794T3/da active
- 2007-12-11 PT PT07855060T patent/PT2125794E/pt unknown
- 2007-12-11 HR HR20100641T patent/HRP20100641T1/hr unknown
- 2007-12-11 DE DE602007010041T patent/DE602007010041D1/de active Active
- 2007-12-11 CA CA002673564A patent/CA2673564A1/en not_active Abandoned
- 2007-12-11 US US12/516,251 patent/US8063212B2/en not_active Expired - Fee Related
- 2007-12-11 KR KR1020097012768A patent/KR101080594B1/ko not_active Expired - Fee Related
- 2007-12-11 ES ES07855060T patent/ES2351371T3/es active Active
- 2007-12-11 AU AU2007334040A patent/AU2007334040B2/en not_active Ceased
- 2007-12-11 SI SI200730463T patent/SI2125794T1/sl unknown
- 2007-12-11 RS RSP-2010/0547A patent/RS51526B/sr unknown
- 2007-12-11 CN CN2007800477447A patent/CN101568539B/zh not_active Expired - Fee Related
- 2007-12-11 JP JP2009543062A patent/JP2010513553A/ja not_active Withdrawn
- 2007-12-11 PL PL07855060T patent/PL2125794T3/pl unknown
- 2007-12-11 MX MX2009006635A patent/MX2009006635A/es active IP Right Grant
- 2007-12-11 WO PCT/US2007/087046 patent/WO2008076705A1/en not_active Ceased
- 2007-12-11 BR BRPI0720607-0A2A patent/BRPI0720607A2/pt not_active IP Right Cessation
- 2007-12-11 AT AT07855060T patent/ATE485291T1/de active
- 2007-12-11 EP EP07855060A patent/EP2125794B1/en active Active
-
2010
- 2010-11-26 CY CY20101101083T patent/CY1110950T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101568539B (zh) | 2012-04-25 |
| EP2125794A1 (en) | 2009-12-02 |
| MX2009006635A (es) | 2009-06-30 |
| PT2125794E (pt) | 2011-01-10 |
| CY1110950T1 (el) | 2015-06-10 |
| BRPI0720607A2 (pt) | 2014-04-08 |
| RS51526B (sr) | 2011-06-30 |
| US20100081641A1 (en) | 2010-04-01 |
| ATE485291T1 (de) | 2010-11-15 |
| HRP20100641T1 (hr) | 2010-12-31 |
| SI2125794T1 (sl) | 2011-02-28 |
| KR20090086111A (ko) | 2009-08-10 |
| EP2125794B1 (en) | 2010-10-20 |
| CN101568539A (zh) | 2009-10-28 |
| JP2010513553A (ja) | 2010-04-30 |
| EA200970616A1 (ru) | 2009-10-30 |
| DK2125794T3 (da) | 2011-01-24 |
| AU2007334040A1 (en) | 2008-06-26 |
| KR101080594B1 (ko) | 2011-11-04 |
| AU2007334040B2 (en) | 2012-02-16 |
| ES2351371T3 (es) | 2011-02-03 |
| EA016178B1 (ru) | 2012-02-28 |
| US8063212B2 (en) | 2011-11-22 |
| CA2673564A1 (en) | 2008-06-26 |
| PL2125794T3 (pl) | 2011-04-29 |
| WO2008076705A1 (en) | 2008-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200621786A (en) | Condensed pyrazole derivatives, their preparation and application in therapeutics | |
| SI2091948T1 (sl) | Novi inhibitorji glutaminil ciklaze | |
| EA200701176A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их | |
| MY142807A (en) | Benzimidazole derivative and use thereof. | |
| TW200642683A (en) | Heterocyclic compound | |
| MX2012000441A (es) | Derivados de 1,2,4-tiazolidin-3-ona y uso en el tratamiento del cancer. | |
| EA201001669A1 (ru) | Замещенные пиримидин-5-карбоксамиды 281 | |
| ATE437872T1 (de) | Proteinkinaseinhibitoren | |
| TNSN07275A1 (fr) | Derives de triazole substitues, servant d'antagonistes d'ocytocine | |
| CY1107956T1 (el) | Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον | |
| DE602008001725D1 (de) | 1-(1-benzylpiperidin-4-yl)benzimidazol-5-carbonsäurederivate zur behandlung von diabetes mellitus | |
| EA201000050A1 (ru) | Замещенные бициклолактамные соединения | |
| TW200635585A (en) | Monocyclic substituted methanones | |
| MA38315A1 (fr) | Composés tétracycliques substitués par un hétérocycle et procédés pour les utiliser pour le traitement de maladies virales | |
| DE602004008959D1 (de) | Benzoäbüä1,4üdioxepinderivate | |
| DE602007001463D1 (de) | Pyrimidin-, chinazolin-, pteridin- und triazinderivate | |
| MX2010001020A (es) | Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas. | |
| DE602005016297D1 (de) | Antithrombotische diamide | |
| MX2010001566A (es) | Derivado de aminopirazolamida. | |
| MX2007013624A (es) | Inhibidores de proteina cinasa. | |
| DE602007010041D1 (de) | Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs | |
| TW200716547A (en) | Piperidin-4-yl-amide derivatives | |
| DE602007011434D1 (de) | 1h-indol-5-ylpiperazin-1-ylmethanonderivate | |
| MY158069A (en) | Tricyclic compound and pharmaceutical use thereof | |
| DE602007008952D1 (de) | Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8328 | Change in the person/name/address of the agent |
Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN |